Wednesday, January 25, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Antimicrobial Resistance

Anti-Bacterial Fabrics for Fight Against Superbugs

by Global Biodefense Staff
March 6, 2016
Prototype anti-super-bacterial masks

Prototype anti-super-bacterial masks. Credit: UNIST

An industry-academic collaborative group affiliated with Ulsan National Institute of Science and Technology (UNIST) has successfully engineered anti-bacterial fabrics that are effective against the super-bacterium, Staphylococcus aureus.

This anti-bacterial fabric was developed using a natural bacterial pigment called ‘Violacein’, which is violet pigment naturally made by bacteria found in nature, and is reported to have antibacterial, antiviral, antiprotozoal and anticancer effects.

See also: Superbugs and Superdrugs: An Interview with BARDA

The research team at UNIST, led by Prof. Robert J. Mitchell, extracted crude violacein using a self-developed production method and this was used to dye the cotton fabric. The team discovered that this fabric blocked the growth of MRSA and other multi-drug resistant S. aureus strains by 99.9%.

This widespread use of antibiotics has resulted in the ongoing and ever-increasing prevalence of antibiotic-resistant bacteria, with more than 0.7 million patients dying each year from these “superbugs”. Moreover, nosocomial infections, otherwise known as hospital-acquired infections, have become a growing problem worldwide and South Korea is no exception, scientists say.

See also: Antibiotic Resistant Bacteria Countermeasure Accelerator

“This is first case where an antibacterial fabric was produced using violacein. This fabric has the possibility to reduce the impact of super-bacterial infections,” said Prof. Mitchell. “We hope this donation will help public health.”

The work was supported by a grant from the Korea Institute for Advancement of Technology (KIAT) through the EUREKA program.

Tags: AntimicrobialsAntiviralsASPRBARDAHHS

Related Posts

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions
Pathogens

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
The device appears smaller than a playing card, transparent, with visible channels branching off.
Medical Countermeasures

How Organ-on-a-chip Models Could Grease the Drug Development Pipeline

January 10, 2023
DARPA Pursues Advanced Threat-Detection for Crop Defense
Biosecurity

DARPA Pursues Advanced Threat-Detection for Crop Defense

January 3, 2023
Load More

Latest News

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023

Biodefense Headlines – 17 January 2023

January 17, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC